FCCC LOGO Faculty Publications
Hegde SR , Iffrig K , Li TY , Downey S , Heller SJ , Tokar JL , Haluszka O
Double-balloon enteroscopy in the elderly: safety, findings, and diagnostic and therapeutic success
Gastrointestinal Endoscopy. 2010 May;71(6) :983-989
PMID: ISI:000277700500015   
Back to previous list
Abstract
Background: Double-balloon enteroscopy (DBE) is an important tool in the evaluation and management of small-bowel disease. Limited data are available on the safety, findings, and outcomes of DBE in elderly patients. Objective: To determine the safety and efficacy of DBE in elderly patients. Design: Single-center, retrospective analysis of prospectively collected database. Setting: Open-access, tertiary care referral center. Patients: A total of 176 patients undergoing DBE (216 procedures) for evaluation of small-bowel disease between August 2007 and August 2008. Interventions: Argon plasma coagulation of bleeding small-bowel lesions. Main Outcome Measurements: DBE complication rate, diagnostic/therapeutic success of DBE. Methods: An age cutoff of 75 years and older was used to designate patients as elderly. Data on complications, indications, findings, and diagnostic and therapeutic success of DBE were compared between age groups. Results: The mean age of patients was 66 +/- 16.4 years (range 20-95 years). DBE was performed in 185 patients, including 60 patients age 75 years and older and 110 patients younger than age 75. An overall complication rate of 0.9% was seen for DBE in this study, with no significant difference between age groups. No major complications were observed in elderly patients. Elderly patients were more likely to have angioectasias (39% vs 23%; P = .01) and were more likely to require endoscopic therapy during DBE (46.8% vs 29.2%; P = .01). Limitations: Single-center, retrospective study. Conclusions: DBE is safe in elderly patients. Elderly patients are more likely to have angioectasias and to require endoscopic therapy during DBE. (Gastrointest Endosc 2010;71:983-9.)
Notes
Hegde, Sanjay R. Iffrig, Kevan Li, Tianyu Downey, Sharon Heller, Stephen J. Tokar, Jeffrey L. Haluszka, Oleh EZEM Boston Scientific ; Fujinon Inc ; Spirus, Inc The following authors disclosed financial relationships relevant to this publication: O. Haluszka: Consultant for EZEM Boston Scientific, and Fujinon Inc; teaches for Spirus, Inc. J. L. Tokar: Speaker and consultant for Fujinon Inc; consultant for Boston Scientific. The other authors disclosed no financial relationships relevant to this publication. 41 Mosby-elsevier; 360 park avenue south, new york, ny 10010-1710 usa 596qq